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Abstract: Optical DNA mapping (ODM) has developed into an important technique for DNA
analysis, where single DNA molecules are sequence-specifically labeled and stretched, for example,
in nanofluidic channels. We have developed an ODM assay to analyze bacterial plasmids—circular
extrachromosomal DNA that often carry genes that make bacteria resistant to antibiotics. As for
most techniques, the next important step is to increase throughput and automation. In this work, we
designed and fabricated a nanofluidic device that, together with a simple automation routine, allows
parallel analysis of up to 10 samples at the same time. Using plasmids encoding extended-spectrum
beta-lactamases (ESBL), isolated from Escherichia coli and Klebsiella pneumoniae, we demonstrate
the multiplexing capabilities of the device when it comes to both many samples in parallel and
different resistance genes. As a final example, we combined the device with a novel protocol for rapid
cultivation and extraction of plasmids from fecal samples collected from patients. This combined
protocol will make it possible to analyze many patient samples in one device already on the day
the sample is collected, which is an important step forward for the ODM analysis of plasmids in
clinical diagnostics.
Keywords: nanofluidics; multiplexing; optical DNA mapping; plasmids; antibiotic resistance
1. Introduction
Optical DNA mapping (ODM) using fluorescence imaging of single long DNA
molecules, pioneered by David Schwartz and others in the early 1990s [1,2], has now devel-
oped into a versatile tool to study genomic DNA. Early work involving DNA mapping
was performed by stretching fluorescently labelled single DNA molecules on a positively
charged or hydrophobic glass surface [3–5]. Although simple to use, the surface stretching
of DNA molecules had drawbacks, in particular with non-uniform DNA stretching. The
advent of micro- and nanofluidic devices opened a new possibility of stretching DNA
molecules in highly confined environments, providing the opportunity to manipulate
single DNA molecules that are not deposited on a surface [6–9].
Early studies of DNA molecules in nanochannels focused primarily on understanding
the physics of confined DNA [9–11]. Soon after, research focusing on targeting the underly-
ing DNA sequence was demonstrated, for example the interaction of the LacI repressor
with specific sites on λ-DNA [12]. This, in turn, opened the possibility to use nanofluidic
channels for ODM studies of DNA [13,14]. Various enzymatic labeling schemes, such
as nick labeling [15], nick-flap labeling [16], and methyltransferase labeling [17], have
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been established and used successfully for ODM in nanochannels. We have developed
an enzyme-free ODM assay, based on one-step competitive binding that creates an emis-
sion intensity variation along the DNA molecule [14,18]. For this, the AT-specific drug
netropsin and the fluorescent dye YOYO-1 are added to the DNA at the same time, with
netropsin:YOYO-1 ratios around 100:1. Netropsin binds to AT-rich regions, leaving the
non-specific YOYO-1 to bind primarily to the GC-rich regions, thus creating an intensity
variation along the DNA, a “DNA barcode” [14]. This labeling protocol has proved to
be useful for various applications, such as plasmid characterization [19,20] and typing of
bacteria [21], as well as human genome analysis [22].
According to the World Health Organization (WHO), antimicrobial resistance (AMR)
is one of the top ten global threats to human health. AMR imposes a huge present and
future burden on global health and economy and requires immediate attention to the
development of new diagnostic tools and antibiotics [23]. One key area where competitive
binding-based ODM has been successfully used is the study of plasmids, circular DNA
molecules not part of the bacterial chromosome, that play an important role in the spread
of AMR. By combining the ODM technique with Cas9-mediated identification of resistance
genes, the method can determine the number of different plasmids in a sample, their size, on
which plasmid a certain resistance gene is located and also use the ODM barcode to identify
and trace plasmids [20]. Our methodology has proven to be useful in understanding the
role of plasmid conjugation, for example, in hospital outbreaks and recurring urinary tract
infections [19,24–27].
To use the assay in a clinical microbiology lab, it is necessary to investigate hundreds
of samples per day. In our previous studies, we used a setup consisting of a single set of
nanochannels where the experiments for one sample can be completed in approximately
one hour. This means that, on a typical workday, up to eight samples could be analyzed.
In this study, we developed a nanofluidic device with the capability to perform ODM
on ten different samples at the same time and, with the help of a simple pressure pump
and epi-fluorescence microscope, we were able to automate the image acquisition process,
thus minimizing the time spent by the researcher in collecting the data. We demonstrate
the principle of the device using model DNA. We then turn to the analysis of bacterial
plasmids containing important resistance genes from different bacterial species. Finally, we
combine the assay with a rapid protocol for extracting plasmids from fecal samples, which
is an important step towards clinical use of the technique.
2. Materials and Methods
2.1. Nanofluidics and System Automation
The nanochannels are of the dimensions of 100 × 150 nm2 (width × height) and there
are 400 nanochannels in each set (Figure 1). Each nanochannel set is connected to their
own inlet microchannel and a shared outlet microchannel (drain). The nanochannels were
fabricated with e-beam lithography, followed by the fabrication of microchannels with
standard photolithography. Sample loading holes were etched via a deep-RIE process and
wafer scale fusion bonding was performed to obtain the micro- and nanoconfinements; the
wafer was finally diced to obtain the individual chips [10,28]. The chips were then mounted
on an acrylic chuck, allowing pre-loading of the sample solutions. This entire setup was
custom-designed to fit on an epi-fluorescence microscope (Zeiss AxioObserver.Z1, Carl
Zeiss AG, Jena, Germany) and has valves to apply N2-pressure with the help of a tabletop
pressure pump (Elveflow OB1 MK3, Paris, France). The setup was automated using a
simple program written within the Elveflow software, which was then designed to trigger
the EMCCD camera (Andor Ixon 888, Oxford Instruments, Abingdon, UK) to collect images.
The Zeiss imaging software (Zen pro blue edition) was programmed to collect images
(20 frames, 100 ms per frame) by moving the microscope stage to designated locations,
thereby collecting one image from each of the ten nanochannel modules. Then, the pump
flushes the DNA molecules out and brings new molecules in for the next set of images to
be taken. This process is repeated until a sufficient amount of data is collected.
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Figure 1. (a) Schematics of the multiplexed nanofluidic chip with inlet, outlet and drain. (b) Fluorescence images of single
DNA molecules obtained simultaneously from the ten different nanochannel modules of the chip. Scale bar: 15 µm. (c) Image
showing the chips and the chip holder enabling automation of pressure-driven flow and ODM using an epi-fluorescence
microscope. Scale bar: 20 mm.
2.2. Sample Preparation
2.2.1. λ-DNA at Different Ionic Strengths
For the experime ts at different ionic strengths, 5 µM λ-DNA (48502 bp, New Eng-
land Biolabs, Ipswich, MA, USA) was mixed with 2 µM YOYO (Invitrogen, Waltham,
MA, USA) and 520 µM netropsin (Sigma-Aldrich, St. Louis, MO, USA) in Tris-Borate-
EDTA buffer (TBE, Sigma-Aldrich, St. Louis, MO, USA); the samples were incubated at
50 ◦C for 30 min and diluted in MilliQ water to obtain the different ionic strengths. 3%
(v/v) β-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA) was added to suppress
photonicking and photobleaching.
2.2.2. Plasmid Samples for ODM
Bacterial strains were cultured for 12–16 h in LB broth supplemented with ampicillin
(30 µg/mL) and plasmids were extracted using a NucleoBond Xtra Midi Kit (Macherey-
Nagel GmbH, Düren, Germany), according to the manufacturer’s instructions. The
eluted DNA was precipitated with 70% isopropa ol and reconstituted wi h TE buffer
(Sig a-Aldrich, St. Louis, MO, USA). The plasmids were treated by either Cas9 (PNA
Bio, Thousand Oaks, CA, USA) with tracrRNA (Dharmacon Inc., Lafayette, CO, USA)
and crRNA (Dharmacon Inc., Lafayette, CO, USA), targeting specific antibiotic resistance
genes (blaCTX-M-14 or blaCTX-M-15), or just the tracrRNA, without crRNA as control, as
shown in the proof-of-concept experiments in Section 3.4. The sequences of the RNA
targeting the blaCTX-M-14 and blaCTX-M-15 genes were 5′AGAGAGCCGCCGCGATGTGC3′
and 5′CCGT GCGATGTATTAGCGT3′, respectively. Aft r the Cas9 reaction, the plas-
mids were mixed with λ-DNA as internal size reference and then fluorescently stained
with YOYO-1 and netropsin. The molar ratio of YOYO-1 to DNA was 1:2, while that of
netropsin to YOYO-1 was 70:1; the staining was performed in 0.5x TBE buffer for 30 min at
50 ◦C. The samples were then diluted to 0.05x TBE to optimize the DNA stretching in the
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nanochannels [13]. B-mercaptoethanol was added at 3% (v/v) to suppress photonicking
and photobleaching.
2.2.3. Clinical Fecal Samples
Five fecal samples (F1–F5) known to contain extended-spectrum beta-lactamase-
producing Enterobacterales were collected. The samples were inoculated in 100 mL of
LB broth supplemented with ampicillin (30 µg/mL) and incubated at 37 ◦C in a shaking
incubator (300 rpm) for 4 h. Plasmid extraction was performed using the NucleoBond Xtra
Midi (Macherey Nagel GmbH, Düren, Germany) plasmid extraction and purification kit,
as in Section 2.2.2.
2.3. Data Analysis
The images collected were first converted into multi-TIFF files. The data obtained
from each nanochannel module were separated, to process data from the different samples
independently. The image data were then processed to identify fluorescent DNA molecules
and their corresponding parameters, including size and the sequence-specific barcodes,
as well as the potential presence of resistance genes (blaCTX-M-14 or blaCTX-M-15). More
details on image analysis for ODM has been discussed in our earlier studies [18,20,29].
Briefly, the identified DNA molecules were first sub-grouped by their mean intensity
and sizes, compared with λ-DNA as a reference. Sub-groups of DNA molecules that are
twice brighter than λ-DNA are circular plasmids [30]. Sub-groups of linearized plasmids
typically have similar intensity as λ-DNA and their sizes are 1.8 times longer than their
circular counterparts [13,30]. Sub-grouped linearized DNA molecules with similar sizes
and intensities were then compared for barcode similarity using Pearson cross correlation
and merged to a consensus barcode. The barcodes were further used for comparison among
isolates (using a p-value approach [27,29]) and for confirming the presence of resistance
genes by identifying consensus double-stranded breaks by Cas9.
For the comparison of experimental barcodes with long-read sequencing in Section 3.4,
FASTA files were converted into a “barcode” based on the binding affinity of YOYO-1 and
netropsin to the underlying sequence. The entire procedure has been discussed in detail in
our earlier work [18].
3. Results and Discussion
3.1. Nanofluidic Device
In this work, we used standard semiconductor fabrication methods to make our
devices [10]. To start with, computer-aided designing (AutoCAD 2020, Autodesk Inc. San
Rafael, CA, USA) was used to prepare the design layout. Nanochannels, microchannels
and sample loading holes were designed and the dimensions were chosen to fit the acrylic
sample holder on which the fluidic device was mounted, enabling N2 pressure-driven flow
of DNA molecules from the sample loading holes to the nanochannels and fluorescence
imaging of the stretched DNA molecules in the nanochannels.
Each device consists of ten microfluidic channels, each having an inlet and an outlet to
assist sample loading and manipulation of DNA molecules in the microchannels (Figure 1).
A common drain-microchannel connects the other end of all the ten sets of nanochannels.
The nanochannel sets were designed with the travelling distance of the microscope objective
in mind and to minimize out-of-focus issues when the objective automatically moves from
one nanochannel set to the next. A total of 400 parallel nanochannels allows tens of DNA
molecules to be stretched at the same time and each nanochannel set spans over an area of
300 × 500 µm2, which makes it possible to image DNA molecules in different regions of
the same nanochannel set.
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3.2. Automation of Pressure-Driven Flow and Imaging
The entropic barrier between the microchannels and the nanochannels allows the DNA
to be preconcentrated in front of the nanochannels at a low applied pressure (400 mbar)
in order to maximize the number of DNA molecules per field of view (see Materials and
Methods). After preconcentration, the DNA molecules were pushed into nanochannels
with a short pulse of high pressure (2000 mBar, 800 ms), sufficient to overcome the entropic
barrier and short enough to keep the DNA molecules within the 500 µm long nanochannels.
The pressure cycles to flush DNA through the microchannels, preconcentrate at the entrance
of the nanochannels and push into the nanochannels were repeated and followed by
automated imaging (see Materials and Methods).
To start with, we performed an experiment to evaluate the effect of preconcentration
time on the number of DNA molecules obtained per image in our setup. We used precon-
centration times from 30 s to 2 min and found that the number of λ-DNA molecules per
image increased linearly with time. For 2 min of preconcentration, we were able to image
~60 λ-DNA molecules per image (Figure 2a). Increasing the preconcentration time further
led to that the channels were too crowded with DNA to allow single DNA molecules to
be imaged. It is worth noting that the starting DNA concentration and the image field of
view also contributes to the number of DNA molecules obtained per image. For all further
experiments, a preconcentration time of 2 min was used.




The entropic barrier between  the microchannels and  the nanochannels allows  the 
DNA to be preconcentrated in front of the nanochannels at a low applied pressure (400 
mbar) in order to maximize the number of DNA molecules per field of view (see Materials 
and  Methods).  After  preconcentration,  the  DNA  molecules  were  pushed  into 




repeated and followed by a toma ed imaging (see Materials and Metho s). 
To start with, we performed a  exp riment to evaluate the effect of preconcentration 














With  an  optimized  automation  procedure  for  DNA  accumulation  and  image 
acquisition, next, we performed a proof‐of‐concept experiment with λ‐DNA molecules at 
different ionic strengths. λ‐DNA in TBE buffer at varying ionic strengths (between 10 mM 
and  100 mM) was  loaded  into  the different  nanochannel modules  of  the device. The 
independent  nanochannel modules made  it  possible  to  study  all  the  different  ionic 







the  aim  was  to  characterize  plasmids  during  an  outbreak  of  extended‐spectrum  β‐
Figure 2. (a) The number of λ-DNA molecules collected per image with increasing preconcentration
time. Error bars are the standard deviations from five images per time point. (b) λ-DNA extension
at seven different ionic strengths measured simultaneously. Each point consists of data for at least
100 molecules. Error bars are standard deviations.
3.3. DNA Stretching at Varying Ionic Strengths
With an optimized automation procedure for DNA accumulation and image acquisi-
tion, next, we performed a proof-of-conce t experiment with λ-DNA molecules at different
ionic stre gths. λ-DNA in TBE buffer at varying ionic strengths (between 10 M and
100 mM) was loaded into the different nanoch nnel modules of the device. Th inde-
pendent nanochannel mo ules made it possible to study all the ifferent ionic strength
conditions at the same time in a single experiment. Images were collected for each ionic
strength and the extensions of the DNA molecules were determined from at least 100 λ-
DNA molecules at each ionic strength. We found that the DNA stretching, as expected,
decreased with the increase in ionic strength (Figure 2b [31–33]).
3.4. Proof-of-Concept ODM Experiment
Next, we turned to demonstrating ODM of plasmids carrying the antibiotic resistance
gene blaCTX-M-15. We selected isolates that were part of a previously published study, where
the aim was to characteriz plasmids during an utbreak of extended-spectrum β-lactamase
(ESBL)-producing Enterobacteriaceae at a Swedish neonatal inten ive care unit [19]. From
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this set of isolates, we picked two ESBL-producing E. coli (ESBL-EC) isolates (P3E1 and
P6E1) that did not carry the blaCTX-M-15 gene of interest on a plasmid and three ESBL-
producing K. pneumoniae (ESBL-KP) isolates (KP-P3, -P4 and -P5) with the blaCTX-M-15 gene
on a plasmid. For all five isolates, two samples were loaded in separate nanochannel
modules in the multiplexed device, one treated with Cas9 targeting the blaCTX-M-15 gene
and one without. P3E1 and P6E1 had plasmids of identical sizes (~130 kb). KP-P3, KP-P4
and KP-P5 each had two plasmids, one of identical size in all isolates (~80 kb, represented
by the dark gray-shaded bars in Figure 3a) and one much larger that varied in size among
the isolates (represented by the light gray bars in Figure 3a). After the Cas9 restriction, we
found that the isolates P3E1 and P6E1 showed no plasmids linearized by Cas9, in line with
the fact that the plasmids found in these isolates did not carry the blaCTX-M-15 gene [19].
However, for the isolates KP-P3, KP-P4 and KP-P5, we identified the blaCTX-M-15 gene on
the ~80 kb plasmid, in accordance with our previously reported results [19]. A comparison
of the barcode between the plasmids in these three isolates also showed that they were
identical and that the location of the blaCTX-M-15 gene agreed with long-read sequencing
(Figure 3b).
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Figure 3. (a) Lengths of plasmids found in the five different isolates. Dark gray-shaded bars
represent plasmids where the blaCTX-M-15 gene was identified. (b) Barcodes of ~80 kb plasmids with
the blaCTX-M-15 gene in the KP-P3, KP-P4 and KP-P5 isolates (black), compared to the theoretical
barcode generated from long-read sequencing (gray). Black squares within the highlighted region
represent the position of the blaCTX-M-15 gene.
3.5. Identification of ultiple Resistance Genes on Plasmids
To further demonstrate the usefulness of the multiplexed device, we extended our
study to detect different resistance genes at the same time. For this, we used isolates M1,
M2 and M3, where we expected to have plasmids carrying either of the two resistance
genes blaCTX-M-14 or blaCTX-M-15 [34]. Each isolate was prepared twice, one with gRNA
targeting blaCTX-M-14 and the other targeting blaCTX-M-15 (Figure 4). The sizes of all the
plasmids identified in these three isolates are shown in Figure 4a and the barcodes of the
plasmids carrying either the blaCTX-M-14 or blaCTX-M-15 gene are presented in Figure 4b. All
three isolates had plasmids of different sizes and barcodes and we identified no similarity
between them.
Micromachines 2021, 12, 1234 7 of 10



































important,  for  example,  for  epidemiological  studies of bacterial  transmission  [19]  and 
plasmid conjugation [24,26]; we have also shown, previously, that detecting identical plas‐
mids in several samples can be a proxy for ongoing clonal outbreaks [25,27]. 
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ti i ti i fi
li i l speci ens can take more than two days if the bacterial coloni s are to be first
identifie and targeted for plasmid extraction. Alternatively, the sample can be directly in-
oculated into the appropriate medium su plemented with antibiotics suita le f r selecti
of t e resista t isolates. e , after over ig t i c batio , las i s ca be extracte a
purified. o ever, this approach increases the turnaround ti e hen using conventional
ethods. erein, e used a odified enrich ent protocol hich is four-ti es faster than
the standard enrich ent protocol (see aterials and ethods), resulting in the orkflo
of the whole analysis being reduced to eight hours. The principle of this brief enrichment
is to remove irrelevant bacterial species and enrich bacteria carrying the AMR plasmids of
interest, thus enabling plasmid extraction from liquid culture instead of bacterial colonies.
We selected five clinical fecal samples (F1–F5) and extracted plasmids using the four-
hour enrichment protocol. We performed a polymerase chain reaction (PCR) followed
by agarose gel electrophoresis that revealed that F1, F4 and F5 encoded the blaCTX-M-14
gene and that all five samples encoded the blaCTX-M-15 gene (Figure 5a). The quality of
sample F4 was not good enough to proceed with the ODM experiments. We investigated
the remaining four samples using ODM, each sample being studied for the blaCTX-M-14 and
blaCTX-M-15 genes (Figure 5). In sample F1, two plasmids were found with blaCTX-M-14 on a
~96 kb plasmid and blaCTX-M-15 on a ~85 kb plasmid, in accordance with the PCR results.
The ODM analysis confirmed that the two plasmids were different. Sample F2 had only
one plasmid and sample F5 had two plasmids, but ODM suggested that neither of the
two resistance genes were located on these plasmids. This could be due to the resistance
genes being present in the chromosomal DNA instead. Isolate F3 had a large plasmid
(~200 kb) carrying the blaCTX-M-15 gene, in accordance with the PCR results. An important
difference between PCR and ODM is that, while the PCR analysis reveals the presence of a
specific gene, the ODM analysis determines on which plasmid a specific gene is located.
This is important, for example, for epidemiological studies of bacterial transmission [19]
and plasmid conjugation [24,26]; we have also shown, previously, that detecting identical
plasmids in several samples can be a proxy for ongoing clonal outbreaks [25,27].
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Figure 5. Identification of blaCTX-M-14 and blaCTX-M-15 genes in clinical fecal samples. (a) Results from
PCR for clinical fecal isolates F1–F5 for genes blaCTX-M-14 and blaCTX-M-15. (b) Barcodes for clinical
fecal samples F1, F2, F3 and F5 showing the presence or absence of the targeted resistance genes on
plasmids, the gene identified and its l cation (black square) along the DNA barcode. The barcodes
are shifted vertically for clarity.
4. Conclusions
In this work, we demonstrate the design and fabrication of a nanofluidic chip with
ten separately addressable modules, where the device can be filled and images acquired
automatically. The device can be used for fundamental studies of the physical properties of
DNA, as demonstrated here by simultaneously studying λ-DNA molecules in buffers of
various ionic strengths. More importantly, the device is perfectly suited for simultaneous
analysis of many clinical samples, illustrated here by analysis of bacterial plasmids carrying
antibiotic resistance genes. The multiplexing can be performed either to study samples
from different patients simultaneously, or to analyze the presence of different resistance
genes at the same time, or a combination thereof. With our traditional devices with one
nanochannel module, one sample can be analyzed per hour. With our new multiplexed
and automated chip, ten samples can be analyzed per hour, which drastically reduces the
time per sample, and at least a hundred samples could be analyzed per device per day. In
a final example, we demonstrate a possible clinical application where we decreased the
time for the enrichment of bacteria from fecal samples, which means that the analysis can
be completed on the same day the sample is collected. This is a crucial improvement for
Micromachines 2021, 12, 1234 9 of 10
future clinical use of the assay for plasmid analysis, but could also be used for, for example,
bacterial identification [21].
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